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Abstract SecA shape and conformational flexibility in solution
were studied by small angle X-ray scattering. Dimeric SecA is a
very elongated molecule, 15 nm long and 8 nm wide. SecA is
therefore four times as long as the membrane is wide. The two
globular protomers are distinctly separated and share limited
surface of intermolecular contacts. ATP, ADP or adenylyl-
imidodiphosphate (AMP-PNP) binding does not alter the SecA
radius of gyration. A SecA mutant that catalyzes multiple rounds
of ATP hydrolysis does not undergo conformational changes
detectable by small angle X-ray scattering (SAXS). We conclude
that SecA conformational alterations observed biochemically
during nucleotide interaction are only small-scale and localized.
The ramifications of these findings on SecA/SecYEG interaction
are discussed.
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1. Introduction
Tra⁄cking of polypeptides across biological membranes is
catalyzed by complex molecular machines, termed preprotein
translocases or translocons [1]. The core of bacterial translo-
case is a complex of the trimeric membrane protein SecYEG
with the peripheral ATPase SecA [2^5]. SecA is a homodimer
[6^8] and can be dissected into two proteolytic fragments,
thought to represent the primary structural elements [9] : the
N-terminal domain (N-domain; residues 1^609) comprising
the high a⁄nity nucleotide binding site NBD1 [9,10] and the
C-terminal domain (C-domain; residues 610^901) that inter-
acts with SecY [11,12] and promotes dimerization [8]. Both
domains can acquire an integral membrane topology [13^15].
Preproteins bind to translocase at SecA [2,3] and trigger
multiple rounds of ATP binding and hydrolysis at NBD1.
As a result, SecA interchanges between a membrane integral
and a more peripheral state at SecYEG [11,16], thus allowing
translocase to move processively along the polymeric sub-
strate [3]. Translocase dissociates from the preprotein only
after its whole chain length has been transported to the peri-
plasm, where it is fully released. SecA cycling is essential for
translocation [16]. However, the molecular mechanism by
which SecA catalyzes substrate vectorial movement is com-
pletely unknown. One hypothesis is that preprotein domains
are physically transported by SecA during its own membrane
insertion [11,16]. The nature and extent of SecA conforma-
tional changes at SecYEG and membrane topology, both es-
sential elements of the above model, have been poorly char-
acterized using only indirect biochemical approaches such as
proteolysis [11,14,16,17] and modi¢cation of cysteinyl residues
[14,17]. Translocase structure at atomic resolution remains
unknown.
Cytosolic SecA is an essential intermediate of SecA mem-
brane cycling [15] and is more amenable to structural analysis
than the integral membrane form. We have now characterized
soluble SecA by employing small angle X-ray scattering
(SAXS). New computational techniques allow low resolution
shape determination from SAXS data [18,19]. Moreover,
SAXS is a direct tool to study conformational changes taking
place in soluble enzymes under native conditions since it pro-
vides accurate information on changes in the radius of gyra-
tion [20]. SAXS has been successfully used to study chaper-
one/polypeptide substrate interactions [21,22]. We have
determined that SecA has an unusually elongated shape.
Moreover, SecA does not undergo any large-scale conforma-
tional changes upon binding or hydrolysis of ATP in solution.
2. Materials and methods
2.1. Bacterial strains and biochemicals
Growth of Escherichia coli BL21.19 (secA13[Am], supF[Ts],
trp(Am), zch: :Tn10, recA: :cat) carrying plasmids pZ52SecA,
pT109N-SecA, pD209N-SecA and pR509K-SecA, and SecA puri¢ca-
tion were as described [10,16]. Nucleotides and trypsin were from
Boehringer Mannheim and chromatography resins from Pharmacia.
2.2. Small angle X-ray scattering and data treatment
All measurements (wavelength of V= 0.15 nm; beamline X33; at
15‡C) [23] were made at the European Molecular Biology Laboratory
Outstation at the Deutsches Elektronen-Synchrotron (Hamburg, Ger-
many). Data were collected on a quadrant multiwire proportional
detector with delay line readout. The sample-detector distances of
1.4 m (low angles), 2.8 and 3.4 m (higher angles) were measured to
cover the range of momentum transfer 0.26 s6 5.0 nm31 (s = 4Z sina/
V, where 2a is the scattering angle). Twenty successive 30-s exposures
were recorded for each sample; there was no evidence of protein
degradation over this time interval. Averaging of frames, corrections
for detector response and beam intensity and bu¡er subtraction were
done using the programs SAPOKO (D.I.S. and M.H.J.K, unpub-
lished) and OTOKO [24]. SecA preparations were s 98% pure and
monodisperse as evidenced by native polyacrylamide gel electropho-
resis and size exclusion chromatography (data not shown). Protein
samples were dialyzed against 20 mM Tris-HCl, pH 7.6, 1 mM
DTT, containing 20 mM NaCl and 5 mM MgCl2 ; nucleotides were
added to the protein sample (80 Wl) and its matching dialysis bu¡er
just prior to the measurements. Protein concentrations were 3^5 mg/
ml (2.8 m and 3.4 m camera lengths) and 15 mg/ml (1.4 m camera
length); no noticeable concentration e¡ect was observed for concen-
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trations up to 7 mg/ml. To avoid systematic errors, the same prepa-
ration of wild-type SecA was used with identical camera settings.
Maximum dimension of the SecA particle was estimated from the
di¡erence curves using the orthogonal expansion program ORTOG-
NOM [25]. The distance distribution function P(r) was evaluated by
the indirect transform package GNOM [26,27]. These data also yield
the forward scattering I(0), which is proportional to the molecular
weight of the solute, and the radius of gyration (Rg) of the particle.
2.3. SecA shape determination
For the ab initio shape determination, the envelope of the particle is
represented by an angular border function F(g), where (g) = (a,B) are
spherical coordinates, which is parameterized as:
Fg 
XL
l0
Xl
m3l
flmYlm 17 > g 1
where flm are complex numbers and Ylm(g) spherical harmonics. The
resolution of this representation is Nr = (5/3)1=2ZRg/(L+1), and the
number of parameters for a general case (L+1)2. The non-linear min-
imization program SASHA [19,28] employs the algorithms to rapidly
compute the scattering intensities I(s) from such a model [18,28]. The
program starts from a spherical initial approximation and determines
the coe⁄cients flm by minimizing the R-factor
R2I 
XN
j1
fWsjIsj3Iexpsjg2
XN
j1
WsjIexpsj2
2
where N is the number of experimental points and the weighting
function is W(sj) = sj2/[c((sj)/Iexp(sj)], where Iexp(sj) and c(sj) are the
experimental intensity and its standard deviation, in the j-th point,
respectively. As the scattering from intraparticle inhomogeneities
dominates the outer part of the scattering curve, only data up to
s = 2.5 nm31 were used for the shape determination. Moreover, a
constant term was subtracted from the data to force the intensity
decrease as s34 at higher angles (ss 1.5 nm31) in accordance with
Porod’s law for homogeneous bodies [29].
SecA is a homodimer [6^8] and it is logical to assume that it pos-
sesses a twofold symmetry axis. Imposing this symmetry restriction on
the envelope function describing the entire dimeric particle, all flm
coe⁄cients with odd m vanish in Eq. 1 which reduces the number
of free parameters for a given L. Alternatively, F(g) can represent
the shape of the monomer, and the scattering amplitude from the
symmetry-related monomer is generated to yield the intensity from
the dimer [30]. This approach enhances the resolution by parameter-
izing the shape of a monomer rather than that of a dimer, adding only
the distance between monomers as an additional parameter.
3. Results
3.1. Radius of gyration and maximal dimension of the
SecA molecule
SecA was exposed to synchrotron radiation and scattering
data were collected. Data from low angle settings were used to
determine the radius of gyration (Rg). Guinier plots (ln I(s) vs.
s2) for the SecA protein were linear at the low angle end (s2
from 0.04 to 0.16 nm32), and deviate gradually from a least-
squares line at higher angles (s2s 0.2 nm32) indicating that
the protein was monodisperse (Fig. 1A). The maximum di-
mension (Dmax) of the particle was found to be 15.0 þ 0.5
nm (see Section 2). The scattering at 0 angle (forward scatter-
ing; I(0)) is coincident with the direct beam and is propor-
tional to the molecular weight of the scattering molecule. The
I(0) values determined for bovine serum albumin (1110 at 3.8
mg/ml) and for SecA (1890 at 2.2 mg/ml), yield a 200-kDa
molecular weight for SecA, consistent with soluble SecA being
homodimeric [6^8]. Using the length distribution function P(r)
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Fig. 1. Analysis of small angle X-ray scattering data used to deter-
mine SecA Rg and dimensions. A: Guinier curves for soluble, unlig-
anded SecA. Data were recorded at a sample-detector distance of
2.8 m (SecA; b) and 3.4 m (T109N-SecA; R). Solid curves repre-
sent the complete data set. The symbols indicate those data points
used for calculation of a linear least-squares ¢t which is indicated
by the broken lines. B: Distance distribution function of SecA eval-
uated from the experimental data using the program GNOM
[26,27].
Table 1
Radius of gyration of SecA
Protein Radius of gyration (nm)
^ ADP ATP AMP-PNP
SecA 4.52 (4.49, 4.54) 4.47 (4.42, 4.51) 4.48 (4.47, 4.53, 4.47, 4.44) 4.47 (4.48, 4.46)
T109N-SecA 4.39 (4.40, 4.38) 4.45 (4.42, 4.50, 4.42) 4.45 (4.46, 4.41, 4.48) 4.41 (4.38, 4.43)
The Rg values were calculated from distance distribution functions, obtained using the indirect transform method, as implemented in the program
GNOM [26,27,47]. Values in parentheses are individual determinations; bold face values represent the average of individual determinations.
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(Fig. 1B), which analyzes the distribution of distances between
pairs of points in a particle [26], its radius of gyration (Rg)
was determined to be 4.47 þ 0.06 nm. Similar values were ob-
tained for the point mutants T109N-SecA (Table 1, see be-
low), D209N-SecA and R509K-SecA (data not shown). The
distance distribution function is not symmetric around the
calculated Rg of V4.5 nm (Fig. 1B). If SecA were a globular
protein, the P(r) function would be expected to be 0 beyond
approximately 11 nm. Instead, the calculated distribution dis-
plays signi¢cant values up to 15 nm. We conclude that SecA is
an unusually elongated molecule.
3.2. Shape of the SecA dimer
The shape of the SecA particle was determined using data
from the high angle setting. The resolution of the shape is
determined by the parameter L (see Eqs. 1 and 2, Section 2)
and depends on the information content in the scattering
data. The latter is related to the number of the Shannon
channels (Ns) covered by the experimental range,
Ns = Dmaxsmax/Z [31,32]. Low resolution shape determination
provides an unambiguous solution if the number of independ-
ent parameters in the model does not exceed 1.5 Ns [20]. Our
data with a value Ns = 12 should allow us to perform the
shape determination of the entire dimer with L = 4 or 5 (13
and 18 free parameters, respectively). However, attempts to ¢t
the scattering data using a single shape representation failed
at this level of resolution. A typical best ¢t at L = 4 yields
RI = 2.2% and displays systematic deviations from the exper-
imental data starting from the onset of the ¢rst shoulder (Fig.
2A,B). The obtained shapes contained arti¢cially enhanced
contributions from higher harmonics (not shown) presumably
due to the elongated nature of SecA.
Taking an alternative approach, we represented the low
resolution structure of SecA in terms of the shape of its mono-
meric part (see Section 2; [30]). At the multipole resolution
L = 3, the number of independent parameters (shape coe⁄-
cients plus the distance vd between the monomers) was 15
(the reduction by two parameters is due to arbitrary shifts
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Fig. 2. Determination of SecA shape in solution. A: Experimental scattering curve showing the ¢t of the data used to construct the SecA shape
models. The curve of the mathematical ¢t using a single dimeric shape model at L = 4 (dashed lines) and the curve calculated from the restored
two-monomer model at L = 3 (dotted lines; presented in panel C below) were superimposed on the curve of the experimental data from SecA
solution scattering (solid line with error bars). B: The shaded area between s values of 0.8 and 1.6 nm31 of plot A has been enlarged to allow
better comparison of the curves. C: Low resolution shape model of the SecA molecule consisting of two monomers. SecA is calculated to be
an elongated particle with approximate maximal dimensions 15U8 nm. The best-¢tting shape model for SecA is shown from three di¡erent
view points (views 1^3). View 1: the twofold axis coincides with the Z axis (normal to the plane of the paper), the two monomers are sepa-
rated along the Y axis; a rotation of 90‡ about the X axis produces view 2 where the twofold axis coincides with Y and the two monomers are
separated along Z ; view 3 is view 2 rotated 90‡ around Y so that the twofold axis coincides with Y and the two monomers are separated along
Z. In all three views the orientation of SecA relative to the membrane plane is hypothetical. SecA could also be positioned parallel to the mem-
brane if the shape in view 3 is rotated along Z by 180‡ (not shown). For comparison of relative sizes, schematic representations of a lipid bi-
layer membrane (shaded rectangle; thickness of 3.4^4 nm [43,44] encompassing a hydrophobic core of V3 nm [44]) and of a SecYEG trimer
(white rectangle) are also shown, drawn to scale. SecYEG diameter was estimated from the crystallographically determined dimensions of mem-
brane proteins, such as the potassium channel from Escherichia coli [44] and the photosystem I from Synechococcus [45]. Each transmembrane
helix in these proteins occupies V2.7 nm2 [43^46]. SecYEG (with a stoichiometry of 1:1:1) is predicted to contain 15 membrane-spanning
K-helices [2]. Tightly packed SecYEG would occupy an area of V40 nm2, corresponding to a diameter of V7 nm.
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of the dimer along the twofold axis and its rotation around
this axis). The restored structure at a spatial resolution of 3.3
nm is presented in Fig. 2C and yields an excellent ¢t to the
experimental data, with RI = 1.5% (Fig. 2A,B). The solution is
stable to the initial approximation and also to the initial
choice of vd. Several minimization runs yielded the monomer
shapes and arrangements similar to those presented in Fig. 2C
(views 1^3) yielding the radius of gyration of the monomer
Rgm = 3.3 þ 0.1 nm and the separation of the centres of mass
of the monomers vd = 5.9 þ 0.3 nm. The maximum width of
the molecule along its short axis was calculated to be 8 nm
(Fig. 2C, view 2). The shape representation in Fig. 2C illus-
trates the anisometric nature of the SecA particle. The two
protomers appear to be relatively globular and are distinctly
separated from each other. A single low resolution angular
envelope function centered in the middle of the homodimer
cannot provide an adequate description of the entire shape,
thus explaining the poor ¢t obtained for the single shape
approximation (Fig. 2A,B).
3.3. E¡ect of nucleotides on SecA conformation studied by
SAXS
SecA binds ATP and ADP in solution with high a⁄nity in
the absence of any other ligands [33^36]. Using proteolysis
and tryptophan £uorescence, nucleotide binding was shown
to a¡ect SecA conformation [34^36]. However, these indirect
approaches cannot provide a true measure of the scale of the
conformational change. To determine the extent of SecA
physical £exibility during nucleotide interaction we examined
the e¡ect of nucleotides on SecA shape directly, by SAXS.
SecA scattering data were collected in the presence of three
nucleotides (ATP, ADP and AMP-PNP) known to a¡ect
SecA conformation in solution and at the membrane
[4,11,14,16,34,35]. Rg values for SecA in the presence or ab-
sence of nucleotides were similar (Table 1). To exclude the
possibility that this result was due to reduced sensitivity of
the experimental method, we extended our data collection to
an s value of 5 nm31. Scattering at higher angles is more
sensitive to structural changes and the higher protein concen-
trations used result in better signal-to-noise ratios. However,
even under these conditions, there is no detectable nucleotide-
dependent conformational change in SecA (Fig. 3). We ruled
out the possibility of an inherent problem in our SecA prep-
arations since under the same experimental conditions used
for the SAXS experiments we could demonstrate changes in
the trypsinolysis pro¢le caused by the binding of ADP (S.
Karamanou, E. Vrontou, G. Sianidis and A.E., manuscript
in preparation) as described previously [36]. Finally, since
the ADP conformation of SecA is very stable ([36], S. Kara-
manou and A.E., unpublished results) it is unlikely that the
nucleotide-induced conformations are too short-lived to be
detected by SAXS.
Could it be that multiple rounds of ATP hydrolysis, more
closely resembling SecA engaged in translocation, are required
for substantial conformational changes to occur? In contrast
to the basal ATPase activity of soluble SecA, translocation
ATPase activity (observed in the presence of membranes
and preprotein) is high level [2,33]. We tested the requirement
for ATP hydrolysis by employing T109N-SecA, a mutant
which is translocation competent ([10], A.E., unpublished re-
sults) but has a basal ATPase activity increased severalfold
over that of wild-type SecA [10]. T109N-SecA displays similar
Rg values in the presence or absence of ATP (Table 1) indi-
cating that SecA shape remains largely unaltered. We con-
clude that the nucleotide-induced conformational changes in
soluble SecA observed by proteolysis and indirect £uorescence
are small and localized.
4. Discussion
We have measured the small-angle X-ray scattering of SecA
and determined the low resolution structure of the SecA dimer
in solution. To our knowledge, this is the ¢rst determination
of SecA shape and dimensions. Furthermore, independently
of any previous model, we demonstrated that SecA does not
undergo any major shape alteration upon interaction with
nucleotides. These results give rise to a number of testable
hypotheses and necessitate an evolution of current models
of the molecular mechanism of SecA membrane cycling
[2,11], the extent of SecA periplasmic exposure and £exibility
of SecA domains [2] and the physical dimensions and shape of
SecA/SecYEG complexes [13].
The SecA particle is very elongated, 15 nm long and 8 nm
wide (Fig. 2C). The dimer is organized in two independent
and distinctly separated spheres with a limited surface of in-
teraction between the protomers. The structural isolation of
the protomers suggests that the two primary N- and C-do-
mains of SecA lie in close proximity in three-dimensional
space. This would explain why both domains are found to
be membrane-inserted [13,14] and why regions of the C-do-
main are important for ATP binding to the N-domain [8,34].
The model presented here ¢ts almost perfectly to the exper-
imental data suggesting a unique and rigid dimeric SecA
shape in solution (Fig. 2C). Nevertheless, it cannot be ex-
cluded that our model represents an ‘average’ structure out
of a set of di¡erent conformations of the protein. Further-
more, in building the model it was assumed that the proto-
mers are symmetrical but slight di¡erences in the structure of
each protomer are possible. These questions will be resolved
when a high resolution structure becomes available.
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Fig. 3. SAXS analysis of nucleotide-SecA interaction. The curves
represent data measured at two sample-detector distances and two
protein concentrations. Scattering from SecA at a concentration of
4 mg/ml was measured at 2.8 m (low angle) and merged with data
recorded using a 1.4-m camera length and a protein concentration
of 15 mg/ml. The program MERGER (M.H.J.K., unpublished) was
used to match the two curves in the region from s = 0.502 to
s = 0.628 nm31. The I(0) values have been altered so that the curves
are separated su⁄ciently for comparison. The curves are superim-
posable except at the higher angle end, which is relatively noisy and
sensitive to errors in bu¡er subtraction. SecA was in 20 mM Tris-
Cl, pH = 7.6, 20 mM NaCl and 5mM MgCl2 ; nucleotides were
present at a concentration of 2 mM.
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E. coli SecA has proven recalcitrant to structure elucidation
by conventional crystallography [37]. In contrast, SAXS has
provided us with a rapid and powerful method to determine
SecA structure, albeit at low resolution. A low resolution
electron microscopy analysis of thin-sectioned SecA crystals
has been presented, but the projection images of the crystal
were not su⁄cient to determine SecA shape [37]. A ‘dumbbell’
shape, apparent in one of the projections, was interpreted as
two SecA dimers forming tetramers or octamers in the crystal
lattice. Both the small size (12 nm) and the pattern of electron
density of the proposed SecA dimer do not match our model
of soluble SecA. Furthermore, in agreement with biochemical
measurements [6^8], in all our SAXS experiments, only a di-
meric form of soluble SecA was detected even at high protein
concentrations. It may be that the orientation of SecA in the
three-dimensional crystals is such that the particle shape is not
evident when viewed in projection.
How does SecA associate with SecYEG? Given its elon-
gated shape, membrane-inserted SecA could acquire either
one of two possible orientations: one perpendicular and one
parallel to the membrane plane (Fig. 2C, views 1^3). In the
former (view 1), only one pole of the dimer (e.g. one of the
two protomers) would be expected to insert. In the latter
orientation (view 3), central parts of the dimer, consisting of
regions from both protomers, would insert. In either case,
intermolecular asymmetry, which is expected to be important
for enzymatic processivity [3], can be established. Available
data, obtained using proteolysis [11,13,15,17,38,39] and acces-
sibility to sulfhydryl-reacting reagents [14,17], cannot discrim-
inate between the two topologies. During SecA association
with the signi¢cantly smaller SecYEG trimer (Fig. 2C), the
sheer size of SecA (almost four times the membrane thickness;
see Fig. 2C) is bound to sterically in£uence translocase shape
and stoichiometry. SecA membrane-inserted at SecYEG is not
laterally accessible to labeling from the lipid phase [40,41],
suggesting that membrane-embedded domains of SecA may
be largely shielded from phospholipids by SecYEG. A single
SecYEG trimer may be too small to envelop the gargantuan
SecA molecule. Alternatively, as was proposed for its eucary-
otic homologue Sec61 [42], bacterial translocase may comprise
several SecYEG trimers.
SAXS provides a direct measure of protein conformational
dynamics. Our results indicate that the overall shape of SecA
remains unaltered when it interacts with ATP or ADP (Fig. 3
and Table 1). Conformational changes during soluble SecA-
nucleotide interaction have been inferred from changes in
proteolytic susceptibility and tryptophan £uorescence
[15,35,36,38]. We too have detected ADP-induced changes in
SecA using trypsinolysis (S. Karamanou, E. Vrontou, G. Sia-
nidis and A.E., manuscript in preparation). However, as
documented previously, this change is localized to a trypsin-
sensitive loop in the middle of the sequence [36]. We conclude
that nucleotide binding to soluble SecA does not cause sig-
ni¢cant motions of large domains or of whole protomers
which would be detectable by SAXS [20] but rather only lim-
ited, localized structural alterations. SecA shape and dimen-
sions determined by SAXS provide the ¢rst baseline against
which all other conformational changes can now be measured
in a quantitative manner.
How £exible is the 15U8-nm SecA particle in the mem-
brane plane during translocation? Binding of SecY, lipid
and preprotein may promote low energy states of SecA. An
important element of SecA-mediated translocation was pro-
posed to be a substantial conformational change leading to
membrane insertion of the 30-kDa C-domain [11,16]. How-
ever, recent experiments suggest that the C-domain of SecA
may not insert in the membrane independently of the N-do-
main [13] and, moreover, the organization of soluble and
membrane-bound SecA appears to be similar [9,12,14,15]. It
cannot be excluded that movement of the N- and C-domains
of SecA relative to each other during translocation is less
dramatic than was originally suggested by proteolysis [11].
An attractive alternative mechanism suggested by the SecA
shape (Fig. 2C) could involve rotational movement of the
two protomers. SAXS is not appropriate to resolve these is-
sues since SecA scattering cannot be deconvoluted from that
of lipids, membrane subunits of translocase and preprotein.
To elucidate SecA membrane topology, conformations and
SecYEG interactions, additional quantitative biophysical
methods will be required.
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